Webcast: Exploring the opportunity for women’s health in emerging markets
With women accounting for half of the global population, women’s healthcare is an important market for the pharmaceutical industry.
When thinking about women’s health, we tend to think about diseases which are linked specifically to female biology. However, it is important to not over-simplify this definition; women’s healthcare also includes diseases which are more prevalent in women and health purchasing behaviour which is more common among females (e.g. aesthetic treatment), all of which present huge opportunities for the pharma industry
Furthermore despite persistent gender wage gaps, women globally earn and own more than ever before and are expected to control nearly 75 percent of discretionary spending worldwide by 2028.
In emerging markets, the women's health space is also deeply influenced by gender roles and societal attitudes to sex and reproduction. It is extremely dynamic from a global perspective; as such, the opportunity for women’s health varies widely from one country to another. An understanding of this and the associated challenges is fundamental when defining and establishing the opportunity for pharmaceutical companies in this area.
Download this complimentary webcast in which market research consultants Sue Rees and Helen Mace explore the opportunity for women’s health in emerging markets. They will discuss why understanding and improving women’s health in emerging markets can be challenging and how market research can be used to understand behaviours and attitudes to different women’s health issues. Finally they’ll outline what strategies global pharma can develop to support women and overcome these challenges.
An overview of women’s health
A summary of what women’s health means in emerging markets and key environmental influences e.g. societal pressures, gender / cultural norms and financial resource.
Areas of opportunity for pharma
Specific examples in the context of fertility, aesthetics and sexual dysfunction will be referenced to highlight the significant opportunity for pharma /healthcare.
Research challenges and considerations
in order to conduct successful research and truly maximise the opportunity for pharma / healthcare, we will talk through challenges associated with women’s health in emerging markets and discuss what can be done to overcome / ease these.
If you are unable to attend, but would like to view the recording, register for free and we will send you a weblink. Or, if you would like to find out more about our research capabilities in emerging markets or experience in women's health, please feel free to contact us.
Click the image below to view the webcast